EyePoint Pharmaceuticals Inc (EYPT)
8.95
+0.60
(+7.19%)
USD |
NASDAQ |
Nov 22, 16:00
8.935
-0.02
(-0.17%)
After-Hours: 20:00
EyePoint Pharmaceuticals Cash from Operations (Quarterly): -39.03M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -39.03M |
| June 30, 2024 | -20.18M |
| March 31, 2024 | -31.17M |
| December 31, 2023 | -23.11M |
| September 30, 2023 | -15.20M |
| June 30, 2023 | 57.02M |
| March 31, 2023 | -16.84M |
| December 31, 2022 | -12.59M |
| September 30, 2022 | -13.14M |
| June 30, 2022 | -19.12M |
| March 31, 2022 | -20.16M |
| December 31, 2021 | -16.67M |
| September 30, 2021 | -7.787M |
| June 30, 2021 | -10.54M |
| March 31, 2021 | -15.10M |
| December 31, 2020 | 5.895M |
| September 30, 2020 | 1.136M |
| June 30, 2020 | -5.121M |
| March 31, 2020 | -16.34M |
| December 31, 2019 | -11.49M |
| September 30, 2019 | -14.77M |
| June 30, 2019 | -17.11M |
| March 31, 2019 | -13.33M |
| September 30, 2018 | -11.77M |
| June 30, 2018 | -6.081M |
| Date | Value |
|---|---|
| March 31, 2018 | -4.82M |
| December 31, 2017 | -5.038M |
| September 30, 2017 | -5.968M |
| June 30, 2017 | -4.452M |
| March 31, 2017 | -4.543M |
| December 31, 2016 | -5.009M |
| September 30, 2016 | -6.486M |
| June 30, 2016 | -4.347M |
| March 31, 2016 | -4.302M |
| December 31, 2015 | -3.174M |
| September 30, 2015 | -4.493M |
| June 30, 2015 | -3.006M |
| March 31, 2015 | -3.954M |
| December 31, 2014 | 21.25M |
| September 30, 2014 | -3.994M |
| June 30, 2014 | -2.785M |
| March 31, 2014 | -1.852M |
| December 31, 2013 | -2.257M |
| September 30, 2013 | -3.777M |
| June 30, 2013 | -3.38M |
| March 31, 2013 | -1.962M |
| December 31, 2012 | -1.782M |
| September 30, 2012 | -1.621M |
| June 30, 2012 | -1.838M |
| March 31, 2012 | -2.143M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-39.03M
Minimum
Sep 2024
57.02M
Maximum
Jun 2023
-11.48M
Average
-15.15M
Median
Cash from Operations (Quarterly) Benchmarks
| Cassava Sciences Inc | -18.30M |
| Regeneron Pharmaceuticals Inc | 1.291B |
| Adverum Biotechnologies Inc | -21.12M |
| Regenxbio Inc | -40.55M |
| Editas Medicine Inc | -52.59M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 16.20M |
| Cash from Financing (Quarterly) | 11.89M |
| Free Cash Flow | -118.04M |
| Free Cash Flow Per Share (Quarterly) | -0.7457 |
| Free Cash Flow to Equity (Quarterly) | -40.60M |
| Free Cash Flow Yield | -26.02% |